The anti-prostate cancer effect of W. chinensis extracts is ascribed to three active compounds: wedelolactone, luteolin, and apigenin, which inhibit the androgen receptor (AR) signaling pathway in LNCaP and 22Rv1 cells. The gene discussed is AR; the disease is prostate carcinoma.